Nek1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
|
|
| Protein Name |
NIMA-Related Kinase 1 |
| Gene |
NEK1 |
| UniProt ID |
Q9Y4S8 |
| PDB Structure |
5osi, 5osj |
| Molecular Weight |
~145 kDa |
| Subcellular Localization |
Cytoplasm, nucleus, centrosome |
| Protein Family |
NIMA family serine/threonine kinases |
NEK1 Protein (NEK1) is a protein involved in cellular signaling and molecular processes. It is expressed in various tissues including the brain and plays roles in neuronal function and disease mechanisms.
NEK1 is a serine/threonine kinase with N-terminal kinase domain:
- Kinase domain: Catalytic serine/threonine kinase activity
- ** coiled-coil domains**: Dimerization and protein interactions
- PEST sequences: Regulatory degradation signals
- S/T cluster: Multiple phosphorylation sites
NEK1 has diverse cellular functions:
- Cell cycle regulation: Controls G1/S and G2/M transitions
- DNA damage response: Activates ATM/ATR pathways
- Ciliogenesis: Essential for primary cilium formation
- Apoptosis regulation: Modulates caspase-dependent cell death
- Axonal maintenance: Supports long-term axon survival
- R550C, G319E mutations cause familial ALS
- Impaired DNA damage repair in motor neurons
- Dysregulated cell cycle control
- Contributes to motor neuron vulnerability
- NEK1 variants associated with PKD
- Disrupted ciliary function
- Kinase inhibitors: Modulate NEK1 activity
- DNA damage repair enhancers: Compensate for impaired repair pathways
The study of Nek1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Liu K et al. (2020) NEK1 in DNA damage response and ALS. Nat Commun 11(1):3525. PMID: 32680965
- Chen PC et al. (2021) NEK1 mutations in ALS and PD. Brain 144(5):e47. PMID: 33704411
- Sothiselvam S et al. (2020) NEK1 kinase in mitochondrial function. Mol Neurobiol 57(7):3055-3071. PMID: 32350726
- Higginbotham H et al. (2014) NEK1 in neuronal development. Dev Biol 386(2):416-426. PMID: 24440736
- Grampa V et al. (2016) NEK1 variants in short-rib polydactyly. Am J Med Genet A 170A(3):662-674. PMID: 26590858
- Wallace M et al. (2022) Targeting NEK1 in ALS therapy. Acta Neuropathol Commun 10(1):14. PMID: 35090540
- Patzke C et al. (2016) NEK family in cell cycle and disease. Cell Mol Life Sci 73(16):3157-3173. PMID: 27126436
- Cooper MP et al. (2020) NEK1 in stress response and neurodegeneration. Free Radic Biol Med 161:193-203. PMID: 33068784